https://www.biospace.com/medivir-ab-swedish-osteoporosis-drug-begins-trials-in-humans
Medivir AB: Swedish Osteoporosis Drug Begins Trials in Humans - BioSpace
medivir abswedishosteoporosisdrugbegins
https://www.prnewswire.com/news-releases/notice-of-annual-general-meeting-of-medivir-ab-publ-301516763.html
Notice of Annual General Meeting of Medivir AB (publ)
/PRNewswire/ -- The shareholders of Medivir AB (publ), reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the...
annual general meetingmedivir abnoticepubl
https://www.biospace.com/medivir-ab-year-end-report-january-december-2023
Medivir AB - Year-End Report January - December 2023 - BioSpace
Feb 15, 2024 - The clinical efficacy of fostrox in combination with Lenvima continues to improve with median time to progression having increased to over 6 months.
year end reportmedivir abdecember 2023january
https://www.home.saxo/cs-cz/markets/stocks/mvir-xome
Medivir AB akcie | Saxo Bank
Medivir AB develops drugs with a focus on cancer, where unmet medical needs are high.
medivir abakciesaxobank
https://www.prnewswire.com/news-releases/execution-of-the-annual-general-meetings-resolution-on-the-removal-of-share-class-in-medivir-ab-publ-301816218.html
Execution of the annual general meeting's resolution on the removal of share class in Medivir AB...
/PRNewswire/ -- The annual general meeting in Medivir AB (publ), held earlier today on 4 May 2023, resolved to adopt new articles of association, whereby the...
https://www.biospace.com/change-in-the-number-of-shares-and-votes-in-medivir-ab-publ
Change in the number of shares and votes in Medivir AB (publ) - BioSpace
May 31, 2023 - Medivir AB announces that the number of shares and votes in Medivir has changed during May 2023 as a result of the previously announced share issue of 970,500...
in the